| abstract |
The present invention is on a kind of formula (I) compound or its pharmaceutically acceptable salt, esters or stereoisomers：Wherein, R 1 For C 1 ‑C 6 Aldehyde radical；C 1 ‑C 6 Carboxyl；C 6 ‑C 10 Arylamine group C 1 ‑C 6 Alkyl, the wherein aryl are optionally through one or more hydroxyls, C 1 ‑C 6 Alkyl or C 1 ‑C 6 Alkoxy substitutes；C 1 ‑C 6 Alkyl-carbonyl vinyl or C 1 ‑C 6 Alkoxy carbonyl vinyl；R 2 For piperazine glucopyranoside base or H； For singly-bound or double bond.Formula (I) compound or its pharmaceutically acceptable salt, esters or stereoisomers can be used for preparing medicine of the treatment by the relevant disease of the receptor modulators of GLP 1. |